Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Boston Scientific Corporation (BSX) had Weighted-Average Shares Outstanding (Diluted) of 1.47B for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$5.44B |
|
$907.00M |
|
$1.59B |
|
$3.85B |
|
$4.26B |
|
$1.18B |
|
$-119.00M |
|
$1.06B |
|
$1.06B |
|
$905.00M |
|
$905.00M |
|
$905.00M |
|
$905.00M |
|
$1.18B |
|
$1.53B |
|
1.47B |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.47B |
$0.62 |
|
$0.61 |
|
| Balance Sheet Financials | |
$7.97B |
|
$4.13B |
|
$37.24B |
|
$45.22B |
|
$6.43B |
|
$10.91B |
|
$13.62B |
|
$20.04B |
|
$25.17B |
|
$-386.00M |
|
$25.17B |
|
1.45B |
|
| Cash Flow Statement Financials | |
$1.82B |
|
$-2.55B |
|
$-670.00M |
|
$2.15B |
|
$753.00M |
|
$-1.39B |
|
$170.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.24 |
|
-- |
|
-- |
|
0.30 |
|
0.50 |
|
70.71% |
|
21.65% |
|
21.65% |
|
-- |
|
19.48% |
|
16.67% |
|
$1.45B |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.49 |
|
1.78 |
|
50.42 |
|
3.60% |
|
-234.46% |
|
2.00% |
|
2.51% |
|
$17.40 |
|
$0.98 |
|
$1.24 |
|